Cancer as well as cardiovascular, neurodegenerative, infectious and autoimmune diseases impose a heavy burden on mankind. The Center for Translational Molecular Medicine (CTMM) strives to significantly reduce the impact of these diseases and improve the quality of life for those who must live with them.
CTMM is dedicated to the development of Molecular Diagnostics and Molecular Imaging technologies, focusing firmly on the translational aspects of molecular medicine so that scientific results can be applied as quickly as possible in actual patient care. Achieving this objective could enable earlier and more precise diagnosis of disease and the design of highly personalized therapies.
All Dutch university medical centers, several universities and more than 90 companies are involved, actively cooperating with one another to bring new products faster to the patient’s bedside. Currently, 32 CTMM research projects are active, involving a total of 133 partners and a research budget of 321 M€. Duration of the projects is 4 – 5 years, ending in 2015.